I agree that this site is using cookies. You can find further informations here.
X
Hurvitz, Sara A
337  results:
Search for persons X
?
1

Author Correction: Safety analyses from the phase 3 ASCENT ..:

Rugo, Hope S. ; Tolaney, Sara M. ; Loirat, Delphine...
npj Breast Cancer.  10 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Type I interferons, inflammation, and fatigue in a longitud..:

Bower, Julienne E. ; Ganz, Patricia A. ; Irwin, Michael R....
Brain, Behavior, and Immunity.  118 (2024)  - p. 312-317 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Trastuzumab deruxtecan versus trastuzumab emtansine in HER2..:

Cortés, Javier ; Hurvitz, Sara A. ; Im, Seock-Ah...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
4

Pembrolizumab-induced nephrotoxicity in a patient with brea..:

Alkassis, Samer ; Fitzsimmons, Kasey ; Hurvitz, Sara
Therapeutic Advances in Medical Oncology.  16 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
5

Subgroup analyses from the phase 3 ASCENT study of sacituzu..:

Hurvitz, Sara A. ; Bardia, Aditya ; Punie, Kevin...
npj Breast Cancer.  10 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
6

Neoadjuvant palbociclib plus either giredestrant or anastro..:

Hurvitz, Sara A ; Bardia, Aditya ; Quiroga, Vanesa...
The Lancet Oncology.  24 (2023)  9 - p. 1029-1041 , 2023
Link: https://doi.org/10.1016/..
 
?
7

DESTINY-Breast03 trial: some questions remain – Authors' re..:

Hurvitz, Sara A ; Curigliano, Giuseppe ; Egorov, Anton..
The Lancet.  401 (2023)  10389 - p. 1653-1654 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Landscape of Baseline and Acquired Genomic Alterations in C..:

Goetz, Matthew P. ; Hamilton, Erika P. ; Campone, Mario...
Clinical Cancer Research.  30 (2023)  10 - p. 2233-2244 , 2023
Link: https://doi.org/10.1158/..
 
?
9

Final findings from the CONTROL trial: Strategies to reduce..:

Chan, Arlene ; Ruiz-Borrego, Manuel ; Marx, Gavin...
The Breast.  67 (2023)  - p. 94-101 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Tumor biomarkers and efficacy in patients treated with tras..:

de Haas, Sanne L. ; Slamon, Dennis J. ; Martin, Miguel...
Breast Cancer Research.  25 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
11

Rationale and trial design of NATALEE: a Phase III trial of..:

Slamon, Dennis J. ; Fasching, Peter A. ; Hurvitz, Sara...
Therapeutic Advances in Medical Oncology.  15 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
12

Health-related quality of life in the phase III ASCENT tria..:

Loibl, Sibylle ; Loirat, Delphine ; Tolaney, Sara M....
European Journal of Cancer.  178 (2023)  - p. 23-33 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Trastuzumab deruxtecan versus trastuzumab emtansine in pati..:

Hurvitz, Sara A ; Hegg, Roberto ; Chung, Wei-Pang...
The Lancet.  401 (2023)  10371 - p. 105-117 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Genomic analysis of advanced breast cancer tumors from tala..:

Turner, Nicholas C. ; Laird, A. Douglas ; Telli, Melinda L....
npj Breast Cancer.  9 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
15

Analysis of patients without and with an initial triple-neg..:

O'Shaughnessy, Joyce ; Brufsky, Adam ; Rugo, Hope S....
Breast Cancer Research and Treatment.  195 (2022)  2 - p. 127-139 , 2022
Link: https://doi.org/10.1007/..
 
1-15